From: Subclinical cardiovascular disease and frailty risk: the atherosclerosis risk in communities study
Variable | Hs-CTnT (≥14 vs. < 14 ng/L) | NT-proBNP (≥100 vs. < 100 pg/mL) | NT-proBNP (≥300 vs. < 300 pg/mL) | |||
---|---|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
Unadjusted | 2.569 (1.532–4.310) | < 0.001 | 1.903 (1.518–2.386) | < 0.001 | 2.676 (1.505–4.760) | < 0.001 |
Model 1 | 2.156 (1.254–3.708) | 0.005 | 1.643 (1.282–2.105) | < 0.001 | 2.233 (1.244–4.011) | 0.007 |
Model 2 | 2.127 (1.129–4.010) | 0.020 | 1.330 (1.007–1.756) | 0.045 | 2.614 (1.283–5.327) | 0.008 |